Hantavirus Nephropathy in North-Eastern France : Severity Risk Factors and Prognostic Tools (HANTA-NE)

Central Hospital, Nancy, France

Status: Completed

Conditions: Hantavirus Infection; Hantavirus Nephropathy

Treatments: Other: HANTA-NE

Study type: Observational

Funder types: Other

Identifiers

NCT05415904

2022PI034

Details and patient eligibility

About

Hantaviruses are emerging pathogens responsible for hemorrhagic fever with renal syndrome. Severity risks factors aren't consensual in litterature, mostly related to scandinavian cohorts. A prognostic score was created to help patient's orientation in healthcare system but wasn't independantly validated (Hentzien, Emerging infectious diseases 2018).

This retrospective cohort of hantavirus infected hospitalized adults patients in the north-eastern quarter of France between 2013 and 2022 will specify the kidney damage during infection and risk factors for a severe form (defined par acute kidney injury KDIGO 3). The previous prognostic score performance will be evaluated in this cohort.

Enrollment: 101 patients

Sex: All

Ages: 18 to 125 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• hantavirus proven by serology infection
• age above 18 years
• Hospitalisation

Exclusion criteria

• age under 18 years
• fulfill opposition form

Trial design

101 participants in 1 patient group

HANTA-NE

Description:

All adult patient hospitalized for hantavirus infection between 01/01/2013 and 31/12/2022 in North Eastern France

Treatment:

Other: HANTA-NE